FDA orders J&J to cite death risks with taking Natrecor

04/26/2005 | NYTimes.com

Johnson & Johnson is changing the packaging insert for its heart failure drug, Natrecor, to state an increased risk of death associated with the medicine. The firm acted on orders from the FDA that notified Scios, J&J's subsidiary that makes the drug, that the information intended for professionals needed to be revised, citing at least seven published journal studies.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC